WebElaprase (idursulfase) is only available as an IV infusion that’s given by a healthcare provider. The dose of this medication depends on your weight. In general, the dosing of … WebFeb 28, 2024 · In this open label, single arm study, all participants will receive ELAPRASE treatment and a prophylactic ITR. Participants will be treated with ELAPRASE for up to 104 weeks. The prophylactic ITR will start 1 day prior to the start of ELAPRASE. ... Participant has received treatment with any investigational drug within the 30 days prior to ...
Elaprase (Idursulfase Solution): Uses, Dosage, Side
WebThis document addresses Elaprase (idursulfase), an enzyme replacement therapy approved by the Food and Drug Administration (FDA) to treat individuals with Mucopolysaccharidosis II (Hunter syndrome). The mucopolysaccharidoses are a group of inherited metabolic diseases caused by the deficiency of lysosomal enzymes needed to WebElaprase is an FDA (U.S. Food and Drug Administration) approved medication manufactured by Shire Human Genetics Therapies, Inc. It is a hydrolytic lysosomal glycosaminoglycan (GAG)-specific enzyme indicated for the treatment of Hunter syndrome (Mucopolysaccharidosis II, MPS II). cfx + change soap + body namespace
A Safety and Dose Ranging Study of Idursulfase (Intrathecal ...
WebThe main aim of this study is to evaluate the ability of a prophylactic immune tolerizing regimen (ITR) to prevent or reduce the development of high titer anti-idursulfase antibodies in treatment-naïve participants with Hunter syndrome.. In this open label, single arm study, all participants will receive ELAPRASE treatment and a prophylactic ITR. WebElaprase 6 Mg/3 Ml Intravenous Solution Metabolic Disease Enzyme Replacement - Mucopolysaccharidosis - Uses, Side Effects, and More Generic Name(S): idursulfase … WebELAPRASE is a prescription medicine for patients with Hunter syndrome. ELAPRASE has been shown to improve walking ability in patients 5 yrs and older. In patients 16 months to 5 years old, ELAPRASE did not show improvement in disease-related symptoms or … byebyebail.ca